• More genetic markers for inherited testi

    From ScienceDaily@1:317/3 to All on Thu Jul 29 21:30:42 2021
    More genetic markers for inherited testicular cancer identified
    A new meta-analysis increased the number of genetic locations for disease
    by 40 percent

    Date:
    July 29, 2021
    Source:
    University of Pennsylvania School of Medicine
    Summary:
    A meta-analysis of nearly 200,000 men revealed 22 new genetic
    locations that could be susceptible to inherited testicular germ
    cell tumors.



    FULL STORY ==========================================================================
    A meta-analysis of nearly 200,000 men revealed 22 new genetic locations
    that could be susceptible to inherited testicular germ cell tumors
    (TGCT) -- a 40 percent increase in the number of regions known to be
    associated with the cancer. The new findings, published online in Nature Communications, could help doctors understand which men are at the highest
    risk of developing the disease and signal them to screen those patients.


    ==========================================================================
    The multi-institutional meta-analysis was conducted by researchers
    from The international TEsticular CAncer Consortium (TECAC), led by
    Katherine L.

    Nathanson, MD,deputy director of Penn's Abramson Cancer Center and
    Pearl Basser Professor of BRCA-Related Research in the Perelman School
    of Medicine at the University of Pennsylvania.

    In 2017, the TECAC reported an additional 12 loci. The new study brings
    the total number to 78.

    "This latest set of genetic locations is adding to our understanding
    of the inherited drivers of testicular cancer, as we look to improve
    screening among men who may be at high risk," Nathanson said. "Although
    this cancer is curable, identifying these men earlier can help save
    them from having to undergo certain treatments, such as chemotherapy,
    which can have late and unwanted complications." Germ cell tumors
    account for 95 percent of testicular cancer cases. TGCTs are the most
    common cancer in the United States and Europe in white men between the
    ages of 20 and 39. The number of cases has continued to rise over the
    past 25 years in white men and more recently in Latino men. Despite
    significant evidence that susceptibility to these tumors is hereditary,
    CHEK2 is the only moderate penetrance gene in which pathogenic variants
    have been associated with risk of the cancer.

    Genome-wide association studies (GWAS) have been more successful,
    identifying common variations associated with risk of the
    disease. Nathanson and TECAC teams have used the method to find locations
    on chromosomes -- called loci - - that contain variants associated with
    an increased risk of germ cell tumors.



    ==========================================================================
    In the latest study, TECAC researchers analyzed genetic data from 10,156 testicular germ cell tumor cases and 179,683 controls in the largest
    GWAS of TGCT to date.

    The study revealed 22 novel loci. When taken together, the results can
    explain 44 percent of the father-to-son familial risk for testicular
    cancer, the authors said. Men with a high polygenic risk score (in the
    95th percentile) also had a 6.8-fold increased disease risk compared to
    men at the median score.

    Beyond the statistical significance of the new loci, the study
    also demonstrated two relevant biological pathways tied to disease susceptibility, male germ cell development and chromosomal segregation
    during cell division.

    When these pathways go awry, they lead to TGCT tumorigenesis.

    "Results from our investigation provide further understanding of the
    genetic architecture of TGCT, enhance comprehension of the biology of
    male germ cell development, and highlight biological pathways specifically important to TGCT," the authors wrote. "Importantly, we have established
    a polygenic risk score that identifies men at highest risk of disease,
    which could be potentially applied in men with other risk factors,
    such as [undescended testes] or infertility, to be targeted for early
    detection and disease mitigation." Next, researchers will begin to
    further investigate the increase in TGCT cases observed among Latino men
    and if the genetic variants observed in mostly white men also exist in
    that population.

    Nathanson is a co-senior author on the study, along with Peter
    A. Kanetsky, PhD, MPH, of Moffitt Cancer Center.

    TECAC is supported by the National Institutes of Health (U01
    CA164947). The Penn GWAS study was supported by the Abramson Cancer Center
    (P30 CA016520) and the NIH (CA114478). This research was also supported
    in part by the California Cancer Research Program, and with awards from
    the Robert E. and May R. Wright Foundation and the Whittier Foundation.

    ========================================================================== Story Source: Materials provided by University_of_Pennsylvania_School_of_Medicine. Note: Content may be
    edited for style and length.


    ========================================================================== Journal Reference:
    1. John Pluta, Louise C. Pyle, Kevin T. Nead, Rona Wilf, Mingyao
    Li, Nandita
    Mitra, Benita Weathers, Kurt D'Andrea, Kristian Almstrup,
    Lynn Anson- Cartwright, Javier Benitez, Christopher D. Brown,
    Stephen Chanock, Chu Chen, Victoria K. Cortessis, Alberto Ferlin,
    Carlo Foresta, Marija Gamulin, Jourik A. Gietema, Chiara Grasso,
    Mark H. Greene, Tom Grotmol, Robert J. Hamilton, Trine B. Haugen,
    Russ Hauser, Michelle A. T.

    Hildebrandt, Matthew E. Johnson, Robert Karlsson, Lambertus
    A. Kiemeney, Davor Lessel, Ragnhild A. Lothe, Jennifer T. Loud, Chey
    Loveday, Paloma Martin-Gimeno, Coby Meijer, Je're'mie Nsengimana,
    David I. Quinn, Thorunn Rafnar, Shweta Ramdas, Lorenzo Richiardi,
    Rolf I. Skotheim, Kari Stefansson, Clare Turnbull, David J. Vaughn,
    Fredrik Wiklund, Xifeng Wu, Daphne Yang, Tongzhang Zheng, Andrew
    D. Wells, Struan F. A. Grant, Ewa Rajpert-De Meyts, Stephen
    M. Schwartz, D. Timothy Bishop, Katherine A.

    McGlynn, Peter A. Kanetsky, Katherine L. Nathanson, Christian
    Kubisch.

    Identification of 22 susceptibility loci associated with testicular
    germ cell tumors. Nature Communications, 2021; 12 (1) DOI:
    10.1038/s41467-021- 24334-y ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2021/07/210729083424.htm

    --- up 11 weeks, 6 days, 22 hours, 45 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)